- Home
- TOVX vs FORM Comparison
TOVX vs FORM Comparison
Compare TOVX & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOVX | FORM |
|---|---|---|
| Founded | 2001 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3M | 4.5B |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | TOVX | FORM |
|---|---|---|
| Price | $0.21 | $56.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 9 |
| Target Price | N/A | ★ $55.75 |
| AVG Volume (30 Days) | ★ 2.6M | 654.7K |
| Earning Date | 11-12-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.53 |
| Revenue | N/A | ★ $759,313,000.00 |
| Revenue This Year | N/A | $3.97 |
| Revenue Next Year | N/A | $10.24 |
| P/E Ratio | ★ N/A | $104.87 |
| Revenue Growth | N/A | ★ 2.29 |
| 52 Week Low | $0.20 | $22.58 |
| 52 Week High | $2.08 | $61.10 |
Technical Indicators
Market Signals| Indicator | TOVX | FORM |
|---|---|---|
| Relative Strength Index (RSI) | 40.10 | 58.23 |
| Support Level | $0.21 | $54.96 |
| Resistance Level | $0.24 | $60.30 |
| Average True Range (ATR) | 0.03 | 1.95 |
| MACD | 0.00 | -0.22 |
| Stochastic Oscillator | 11.45 | 60.36 |
Price Performance
Historical ComparisonAbout TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.